Senior Clinical Investigator Award to Ingrid Glimelius and Gustav Ullenhag
The Swedish Cancer Society’s grant Senior Clinical Investigator Award has this year been granted Ingrid Glimelius and Gustav Ullenhag at IGP.
The grant is for six years and is awarded clinical researchers to allow them to do research on fifty to seventy per cent of their working time.
Ingrid Glimelius’ research focuses on new therapies for the blood cancer type mantle cell lymphoma. Gustav Ullenhag studies CD40-activating immunotherapy and the effect of follow-up radiological examinations of patients that have undergone skin cancer surgery.
More information:
Swedish Cancer Society, grant decision (Link removed)
Ingrid Glimelius’ research in Gunilla Enblad’s group (Link removed)
Gustav Ullenhag’s research (Link removed)